Sciensus partners with Sentynl Therapeutics to become the exclusive distribution partner of NULIBRY® in Europe
Sciensus, a life sciences business, to become the exclusive distribution partner for Sentynl’s drug NULIBRY in Europe. UNITED STATES, July 12, 2024 /EINPresswire.com/ -- Sciensus, a life sciences business, specialising in patient access, engagement and …